Title: Inflammatory Breast Carcinoma: A Case Report & Review of Literature
Author: Ashwath Narayan Ramji
DOI: https://dx.doi.org/10.18535/jmscr/v7i3.44
Abstract
Inflammatory breast carcinoma is a rare and highly aggressive malignancy. Clinically, the presentation is rapid and macroscopic appearance may be mistaken for a benign inflammatory lesion, showing characteristic pathological signs of inflammation, and prominent peau d’orange appearance. The aggressiveness of the condition automatically grants a T4 status in the AJCC TNM staging system. Here we report a case of 45-year-old female with inflammatory carcinoma of the right breast and briefly discuss relevant literature.
Keywords: inflammatory breast cancer, breast cancer, locally advanced breast cancer.
References
- Hance KW, Anderson WF, Devesa SS, et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 2005; 97:966.
- Anderson WF, Schairer C, Chen BE, et al. Epidemiology of inflammatory breast cancer (IBC). Breast Dis 2005-2006; 22:9.
- Buzdar AU, Singletary SE, Booser DJ, Frye DK, Wasaff B, Hortobagyi GN. Combined modality treatment of stage III and inflammatory breast cancer: M.D. Anderson Cancer Center experience. SurgOncolClin N Am 1995; 4:715-733
- Sidiropoulou Z, Ramalho L, Madureira R. Inflammatory breast cancer: A case report. Breast Care (Basel) 2009;4:397-9
- Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 2005;97(13): 966–975
- Bertucci F, Finetti P, Rougemont J et al.Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res 2005;65(6): 2170–2178.
- Bièche I, Lerebours F, Tozlu S, Espie M, Marty M, Lidereau R. Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin Cancer Res 2004;10(20):6789–6795.
- Walshe JM, Swain SM. Clinical aspects of inflammatory breast cancer. Breast Dis 2005-2006; 22:35.
- Smoot RL, Koch CA, Degnim AC, et al. A single-center experience with inflammatory breast cancer, 1985-2003. Arch Surg 2006; 141:567.
- Dawood S, Merajver SD, Viens P, et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 2011; 22:515.
- Yang CH, Cristofanilli M. Systemic treatments for inflammatory breast cancer. Breast Dis 2005-2006; 22:55.
- Brzezinska M, Williams LJ, Thomas J, Michael Dixon J. Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery. Breast Cancer Res Treat 2016; 160:387.